Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.

Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.

Item
http://www.wikidata.org/entity/Q30695515
IGFBP2 Produces Rapid-Acting and Long-Lasting Effects in Rat Models of Posttraumatic Stress Disorder via a Novel Mechanism Associated with Structural Plasticity.The Development of Rapastinel (Formerly GLYX-13); A Rapid Acting and Long Lasting Antidepressant.Investigational drugs for treating major depressive disorder.The chronic mild stress (CMS) model of depression: History, evaluation and usageSynaptic Plasticity, Metaplasticity and Depression.Modulation of the activity of N-methyl-d-aspartate receptors as a novel treatment option for depression: current clinical evidence and therapeutic potential of rapastinel (GLYX-13).Enhancing NMDA Receptor Function: Recent Progress on Allosteric Modulators.The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus.Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions.NYX-2925 is a novel NMDA receptor-specific spirocyclic-β-lactam that modulates synaptic plasticity processes associated with learning and memory.GLYX-13 Produces Rapid Antidepressant Responses with Key Synaptic and Behavioral Effects Distinct from Ketamine.Convergent Mechanisms Underlying Rapid Antidepressant Action.
P2860

Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.

Item
http://www.wikidata.org/entity/Q30695515
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Rapastinel (GLYX-13) has thera ...... ial prefrontal cortex of rats.
@ast
Rapastinel (GLYX-13) has thera ...... ial prefrontal cortex of rats.
@en
type
label
Rapastinel (GLYX-13) has thera ...... ial prefrontal cortex of rats.
@ast
Rapastinel (GLYX-13) has thera ...... ial prefrontal cortex of rats.
@en
prefLabel
Rapastinel (GLYX-13) has thera ...... ial prefrontal cortex of rats.
@ast
Rapastinel (GLYX-13) has thera ...... ial prefrontal cortex of rats.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Rapastinel (GLYX-13) has thera ...... dial prefrontal cortex of rats
@en
P2093
P2860
P304
P31
P356
P407
P478
P50
P577
P698
P921
P932